Delivery Order SPE2DB22D3501-SPE2DB25FXB33
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,441.94 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count) valued at $2,354.12. This competitive award, issued with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $15,429.77 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,439.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract, which is not subject to any set-aside designation, was competitively awarded and carries an ultimate completion date of August 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the location from which this major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,274.62. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, valued at $1,804.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a ceiling value of $2,596.57. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,613.64 for 100 tablets of Ambien CR 6.25 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,248.18 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceuticals will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXB33Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to fulfill federal pharmaceutical procurement requirements across varying transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/27/25 |